JNMT
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     




First published online February 16, 2010, 10.2967/jnmt.109.068593
doi:10.2967/jnmt.109.068593
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME Activity
Right arrow All Versions of this Article:
jnmt.109.068593v1
38/1/1    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pagnanelli, R. A.
Right arrow Articles by Basso, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pagnanelli, R. A.
Right arrow Articles by Basso, D. A.
Journal of Nuclear Medicine Technology Volume 38, Number 1, 2010 1-3
© 2010 by Society of Nuclear Medicine

Myocardial Perfusion Imaging with 201Tl*

Robert A. Pagnanelli, BSRT(R)(N), CNMT, NCT1 and Danny A. Basso, CNMT, NCT, FSNMTS2

1 Duke University Hospital, Durham, North Carolina; and 2 Cardiac Imaging of Augusta, Augusta, Georgia

Correspondence: For correspondence or reprints contact: Danny A. Basso, CNMT, NCT, FSNMTS, Cardiac Imaging of Augusta, 818 St. Sebastian Way, Ste. 305, Augusta, GA 30901. E-mail: dbasso{at}knology.net

ABSTRACT

The object of this review is to provide information about 201Tl-thallous chloride in radionuclide myocardial perfusion imaging. This technique has experienced a recent resurgence because of the shortage of 99mTc. After reading this article, the technologist will be able to describe the properties and uptake mechanism of 201Tl, the procedure for myocardial perfusion imaging with this agent, and the advantages and disadvantages of thallium, compared with the technetium agents.

Key Words: myocardial perfusion; 201Tl-thallous chloride; SPECT; 99mTc-sestamibi; 99mTc-tetrofosmin




This article has been cited by other articles:


Home page
J. Nucl. Med. Technol.Home page
G. M. Currie, H. Kiat, and J. M. Wheat
Global Contrast in Nuclear Medicine
J. Nucl. Med. Technol., September 1, 2010; 38(3): 115 - 116.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE JOURNAL OF NUCLEAR MEDICINE JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY
Copyright © 2010 by the Society of Nuclear Medicine Technologist Section.